Benefits of VILPA in Young Adults

Benefits of Wearable Acceleration-Monitored Simulated Vigorous Intermittent Lifestyle Physical Activity (VILPA) in Young Adults

The goal of this clinicaltrial is to assess and compare isokinetic performance, surface electromyography, laboratory parameters, and cardiorespiratory function both before and after engaging in vigorous intermittent lifestyle physical activity(VILPA) within a healthy population.

The main question it aims to answer is:

[1] Does VILPA yield effective outcomes? Throughout the course of the trial, participants will engage in a simulated regimen of vigorous intermittent lifestyle physical activity for a duration of 8 weeks. The efficacy of the exercise protocol will be quantified and evaluated through the utilization of a wearable device.

Study Overview

• Status: Completed
• Conditions: Health Behavior; Activity, Motor
• Intervention / Treatment: Behavioral: Vigorous intermittent lifestyle physical activity

• Study Type: Interventional
• Enrollment (Actual): 40
• Phase: Not Applicable

Contacts and Locations

Study Locations

• China
  • Guangdong
    • Guangzhou, Guangdong, China, 510006
      • Guangdong Pharmaceutical University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Healthy Adults
• No exercise habits (more than 3 months)

Exclusion Criteria:

• Exercising ≥ 3 times per week;
• the presence of chronic diseases, such as hypertension, hyperglycemic states, etc;
• have conducted an exercise program in the past three months.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: intervention group; The intervention measures encompass the implementation of simulated vigorous intermittent lifestyle physical activity for all participants. The specific exercise regimen involves performing rope jumping activities three times a day, with each session aimed at surpassing the exercise threshold (not conducted in a continuous manner), where the heart rate should exceed 160 beats per minute. This routine will be undertaken five times a week, continuously for a span of 8 weeks.

Behavioral: Vigorous intermittent lifestyle physical activity; The specific exercise regimen involves performing rope jumping activities three times a day, with each session aimed at surpassing the exercise threshold (not conducted in a continuous manner), where the heart rate should exceed 160 beats per minute. This routine will be undertaken five times a week, continuously for a span of 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Isokinetic strength testing	Isokinetic strength testing with the Isomed 2000	30 minutes
Surface electromyography	a standard surface electromyography system (MyoMove-EOW, NCC, China) was utilized. Surface electrodes were placed using the belly tendon method at 6 specified locations on both sides of the lower legs (anterior tibialis on both sides, gastrocnemius on both sides, and soleus on both sides). The electrode placement positions and operational procedures strictly adhered to the SENIAM guidelines (http://www.seniam.org). During the testing process, root mean square (RMS) and averaged electromyography (AEMG) values were collected to reflect the muscle force and motor unit recruitment of the selected muscle groups.	15 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Blood lipid	encompassing high-density lipoprotein cholesterol (HDL-C) and triglycerides, were assessed using the CardioChek device (Polymer Technology Systems, Inc., 7736 Zionsville Road, USA)	5 minutes

Collaborators and Investigators

• Sponsor: Xiao-dong Zhuang
• Investigators: Study Director: Lizhen Liao, Dr., Department of Health, Guangdong Pharmaceutical University

Study record dates

Study Major Dates

• Study Start (Actual): May 12, 2023
• Primary Completion (Actual): July 10, 2023
• Study Completion (Actual): December 31, 2023

Study Registration Dates

• First Submitted: January 19, 2024
• First Submitted That Met QC Criteria: February 5, 2024
• First Posted (Actual): February 14, 2024

Study Record Updates

• Last Update Posted (Actual): February 14, 2024
• Last Update Submitted That Met QC Criteria: February 5, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Keywords: wearable device; vigorous intermittent lifestyle physical activity; Isokinetic strength testing
• Other Study ID Numbers: K001

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No